TIF has participated in the Annual Training Day of the European Medicines Agency (EMA), held on 23 October 2020.
TIF participants, Ms Lily Cannon (TIF Operations Manager) and Ms Eleni Antoniou (TIF Senior Policy Officer) had the opportunity to be updated on the centralised procedure for approval of medicinal products and how patients can interact in this process.
The involvement of patients throughout the drug approval process has evolved along the 25 years of the EMA’s existence – but has always remained a priority to bring the patient voice to the forefront of the process.
It is noted that TIF is represented on the EMA Patient & Consumer Working Party, Committee for Orphan Medicinal Products (COMP) and in consultations / review of documents by five (5) patient advocates from Europe, members of TIF’s Patient Advocacy Group. All representatives have received appropriate training by TIF and must follow the confidentiality policy of EMA.Notes_Slides